XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Gain/(Loss)
Accumulated Deficit
Total
Beginning balance, shares at Dec. 31, 2021 24,410,393        
Beginning balance, value at Dec. 31, 2021 $ 2 $ 208,867 $ (59) $ (36,392) $ 172,418
Unrealized loss on investments     (585)   (585)
Stock based compensation   1,024     1,024
Net loss       (10,910) (10,910)
Ending balance, shares at Mar. 31, 2022 24,410,393        
Ending balance, value at Mar. 31, 2022 $ 2 209,891 (644) (47,302) 161,947
Beginning balance, shares at Dec. 31, 2021 24,410,393        
Beginning balance, value at Dec. 31, 2021 $ 2 208,867 (59) (36,392) 172,418
Net loss         (22,901)
Ending balance, shares at Jun. 30, 2022 24,418,434        
Ending balance, value at Jun. 30, 2022 $ 2 211,129 (785) (59,293) 151,053
Beginning balance, shares at Mar. 31, 2022 24,410,393        
Beginning balance, value at Mar. 31, 2022 $ 2 209,891 (644) (47,302) 161,947
Unrealized loss on investments     (141)   (141)
Issuance of common stock upon exercise of stock options   14     14
Issuance of common stock upon exercise of stock options (in shares) 8,041        
Stock based compensation   1,224     1,224
Net loss       (11,991) (11,991)
Ending balance, shares at Jun. 30, 2022 24,418,434        
Ending balance, value at Jun. 30, 2022 $ 2 211,129 (785) (59,293) 151,053
Beginning balance, shares at Dec. 31, 2022 24,722,974        
Beginning balance, value at Dec. 31, 2022 $ 2 215,110 (466) (87,903) 126,743
Unrealized gain on investments     265   265
Issuance of common stock upon exercise of stock options   223     223
Issuance of common stock upon exercise of stock options (in shares) 93,966        
Stock based compensation   2,384     2,384
Net loss       (16,520) (16,520)
Ending balance, shares at Mar. 31, 2023 24,816,940        
Ending balance, value at Mar. 31, 2023 $ 2 217,717 (201) (104,423) 113,095
Beginning balance, shares at Dec. 31, 2022 24,722,974        
Beginning balance, value at Dec. 31, 2022 $ 2 215,110 (466) (87,903) $ 126,743
Issuance of common stock upon exercise of stock options (in shares)         200,722
Net loss         $ (35,545)
Ending balance, shares at Jun. 30, 2023 27,601,098        
Ending balance, value at Jun. 30, 2023 $ 3 265,594 (223) (123,448) 141,926
Beginning balance, shares at Mar. 31, 2023 24,816,940        
Beginning balance, value at Mar. 31, 2023 $ 2 217,717 (201) (104,423) 113,095
Unrealized loss on investments     (22)   (22)
Issuance of common stock in connection with ATM, net $ 1 44,282     44,283
Issuance of common stock in connection with ATM, net, shares 2,662,721        
Issuance of common stock upon exercise of stock options   333     333
Issuance of common stock upon exercise of stock options (in shares) 106,756        
Issuance of common stock under ESPP   228     228
Issuance of common stock under ESPP, shares 13,866        
Vesting of restricted stock units, shares 815        
Stock based compensation   3,034     3,034
Net loss       (19,025) (19,025)
Ending balance, shares at Jun. 30, 2023 27,601,098        
Ending balance, value at Jun. 30, 2023 $ 3 $ 265,594 $ (223) $ (123,448) $ 141,926